1. Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am 2021; 50(3): 337–355.
2.
Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health 2019; 7(4): e448–e460.
3.
Ma CX, Ma XN, Guan CH, et al. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol 2022; 21(1): 74, doi: 10.1186/s12933-022-01516-6.
4.
Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol 2017; 12(12): 2032–2045, doi: 10.2215/CJN.11491116.
5.
Stefánsson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000; 78(4): 374–385.
6.
Barnes JA, Eid MA, Creager MA, et al. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease. Arterioscler Thromb Vasc Biol 2020; 40(8): 1808–1817.
7.
Haskas Y, Rizkiani I, Restika I. Literature review: evaluasi metode diabetes self management education (DSME) pada penderita diabetes melitus type 2. Nursing Arts 2020; 14(2): 127–141.
8.
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract 2019; 157: 107843.
9.
Syabariyah S, Nurachmah E, Widjojo BD, et al. The Effect of Vibration on the Acceleration of Wound Healing of Diabetic Neuropathic Foot Ulcer: A Prospective Experimental Study on Human Patients. Healthcare 2023; 11(2): 191, doi: 10.3390/healthcare11020191.
10.
Yunir E, Tahapary DL, Tarigan TJE, et al. Non-vascular contributing factors of diabetic foot ulcer severity in national referral hospital of Indonesia. J Diabetes Metab Disord 2021; 20(1): 805–813.
11.
Adam JM. Komplikasi kronik diabetik masalah utama penderita diabetes dan upaya pencegahan. Jurnal Kedokteran Universitas Hasanudin 2005; 26(3): 53–61 (in Indonesian).
12.
Anwar MC. Cek Daftar Kenaikan UMP Jakarta dari Tahun ke Tahun. Kompas [Internet]. 2021 Nov 7 [cited 17.11.2022]. Available from URL: mon-ey.kompas.com/read/2022/11/28/125127126/cek-daftar-kenaikan-ump-dki-jakarta-dari-tahun-ke-tahun (in Indonesian).
13.
Andriyanto A, Hidayati RN. Literature review: pemanfaatan media promosi kesehatan (smartphone) dalam mencegah dan mengendalikan kadar gula diabetes tipe 2. Jurnal Ners dan Kebidanan 2018; 5(2): 172–177 (in Indonesian).
14.
Tomky D, Cypress M, Dang D, et al. AADE7TM self-care behaviors. Diabetes Educ 2008; 34(3): 445–449.
15.
Association AD. Standards of medical care in diabetes – 2009. Diabetes Care 2009; 32(Suppl. 1): S13.
16.
Goodall TA, Halford WK. Self-management of diabetes mellitus: a critical review. Health Psychol 1991; 10(1): 1–8.
17.
Tristiana RD. Keefektifan Intervensi Psikologis: Motivational Interviewing Program untuk Meningkatkan Manajemen Diri dan Kontrol Glikemik pada Pasien Diabetes Mellitus Tipe 2. Jurnal Ners Lentera 2016; 4(2): 166–177.
18.
Widyaningsih DS, Prasetyowati AT, Harwanto A, et al. Newspaper Leg Exercise to Reduce the Type 2 Diabetes Mellitus Physical Symptoms. Journal of Health Sciences and Medical Development 2022; 1(2): 83–91.
19.
García-Pérez LE, Álvarez M, Dilla T, et al. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 2013; 4: 175–194.
20.
AlHewiti A. Adherence to long-term therapies and beliefs about medications. Int J Family Med 2014; 2014: 479596, doi: 10.1155/2014/479596.
21.
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
22.
Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open 2021; 11(3): e045343.
23.
Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr 2020; 14(4): 351–354.
24.
Galiero R, Pafundi PC, Nevola R, et al. The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy. J Diabetes Res 2020; 2020: 9036847, doi: 10.1155/2020/9036847.
25.
Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes 2021; 15(6): 918–922.
26.
Yang Y, Shang W, Rao X. Facing the COVID-19 outbreak: What should we know and what could we do? J Med Virol 2020; 92(6): 536–537.
27.
López Seguí F, Franch Parella J, Gironès García X, et al. A cost-minimization analysis of a medical record-based, store and forward and provider-to-provider telemedicine compared to usual care in Catalonia: more agile and efficient, especially for users. Int J Environ Res Public Health 2020; 17(6): 2008, doi: 10.3390/ijerph17062008.
28.
Vidal-Alaball J, Acosta-Roja R, Pastor Hernández N, et al. Telemedicine in the face of the COVID-19 pandemic. Aten Primaria 2020; 52(6): 418–422, doi: 10.1016/j.aprim.2020.04.003.
29.
Alromaihi D, Alamuddin N, George S. Sustainable diabetes care services during COVID-19 pandemic. Diabetes Res Clin Pract 2020; 166: 108298, doi: 10.1016/j.diabres.2020.108298.
30.
Franc S, Daoudi A, Mounier S, et al. Telemedicine and diabetes: Achievements and prospects. Diabetes Metab 2011; 37(6): 463–476.
31.
Bashshur RL, Shannon GW, Smith BR, et al. The empirical evidence for the telemedicine intervention in diabetes management. Telemed J E Health 2015; 21(5): 321–354.
32.
McDonnell ME. Telemedicine in complex diabetes management. Curr Diab Rep 2018; 18(7): 42, doi: 10.1007/s11892-018-1015-3.
33.
Marcolino MS, Maia JX, Alkmim MBM, et al. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS ONE 2013; 8(11): e79246.
34.
Lee JY, Lee SWH. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther 2018; 20(7): 492–500.
35.
Shan R, Sarkar S, Martin SS. Digital health technology and mobile devices for the management of diabetes mellitus: state of the art. Diabetologia 2019; 62: 877–887.
36.
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4(1): 1–9.
37.
Elm E, von, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for re-porting observational studies. Ann Intern Med 2007; 147(8): 573–577.
38.
Cuschieri S. The STROBE guidelines. Saudi J Anaesth 2019; 13(Suppl. 1): S31–S34.
39.
Long HA, French DP, Brooks JM. Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence syn-thesis. Research Methods in Medicine & Health Sciences 2020; 1(1): 31–42.
40.
CASP. Critical Appraisal Skills Programme [Internet]. CASP UK. 2023 [cited 1.03.2023]. Available from URL: https://casp-uk.net/.
41.
Patnaik L, Panigrahi SK, Sahoo AK, et al. Mobile health application based intervention for improvement of quality of life among newly diagnosed type 2 diabetes patients. Clin Diabetol 2021; 10(3): 276–283.
42.
Young HM, Miyamoto S, Dharmar M, et al. Nurse coaching and mobile health compared with usual care to improve diabetes self-efficacy for persons with type 2 diabetes: randomized controlled trial. JMIR Mhealth Uhealth 2020; 8(3): e16665.
43.
Poonprapai P, Lerkiatbundit S, Saengcharoen W. Family support-based intervention using a mobile application pro-vided by pharmacists for older adults with diabetes to improve glycaemic control: a randomised controlled trial. Int J Clin Pharm 2022; 44(3): 680–688, doi: 10.1007/s11096-022-01389-5.
44.
Lee EY, Yun JS, Cha SA, et al. Personalized type 2 diabetes management using a mobile application integrated with electronic medical records: an ongoing randomized controlled trial. Int J Environ Res Public Health 2021; 18(10): 5300, doi: 10.3390/ijerph18105300.
45.
Kebede MM, Schuett C, Pischke CR. The role of continuous glucose monitoring, diabetes smartphone applications, and self-care behavior in glycemic control: results of a multi-national online survey. J Clin Med 2019; 8(1): 109 doi: 10.3390/jcm8010109.
46.
Yamaguchi S, Waki K, Nannya Y, et al. Usage patterns of GlucoNote, a self-management smartphone app, based on ResearchKit for patients with type 2 diabetes and prediabetes. JMIR Mhealth Uhealth 2019; 7(4): e13204.
47.
Joshua SR, Abbas W, Lee JH. M-Healthcare Model: An Architecture for a Type 2 Diabetes Mellitus Mobile Application. Appl Sci 2023; 13(1): 8, doi: 10.3390/app13010008.
48.
Abd-alrazaq AA, Suleiman N, Baagar K, et al. Patients and healthcare workers experience with a mobile application for self-management of diabetes in Qatar: A qualitative study. Computer Methods and Programs in Biomedicine Update 2021; 1: 100002, doi: 10.1016/j.cmpbup.2021.100002.
49.
Rossmann C, Riesmeyer C, Brew-Sam N, et al. Appropriation of mobile health for diabetes self-management: lessons from two qualitative studies. JMIR Diabetes 2019; 4(1): e10271, doi: 10.2196/10271.
50.
Jeffrey B, Bagala M, Creighton A, et al. Mobile phone applications and their use in the self-management of type 2 diabetes mellitus: a qualitative study among app users and non-app users. Diabetol Metab Syndr 2019; 11(1): 1–17.
51.
Adu MD, Malabu UH, Malau-Aduli AEO, et al. User retention and engagement with a mobile app intervention to support self-management in Australians with type 1 or type 2 diabetes (my care hub): mixed methods study. JMIR Mhealth Uhealth 2020; 8(6): e17802.
52.
Adu MD, Malabu UH, Malau-Aduli AEO, et al. The development of My Care Hub mobile-phone app to support self-management in Australians with type 1 or type 2 diabetes. Sci Rep 2020; 10(1): 1–10.
53.
Izahar S, Lean QY, Hameed MA, et al. Content analysis of mobile health applications on diabetes mellitus. Front Endocrinol (Lausanne) 2017; 8: 318.
54.
Hisan UK, Irianto I, Ghazali I, et al. Telemedicine and COVID-19 Pandemic: Valuable Lessons for Future Implementa-tions. JNEST 2022; 1(2): 63–68.
55.
Rahmini JA, Rahayuningtyas DK. Inovasi Kesehatan Terkini Sebagai Strategi Efektif Pada Manajemen Diabetes Di Masa Pandemi: Sebuah Tinjauan Literature. JKEP 2020; 5(2): 196–211.
56.
Wahyudi CT. Aplikasi M-Health Dalam Upaya Monitoring Perawatan Pada Pasien Diabetes Mellitus: Studi Literatur. Jurnal JKFT 2019; 4(2): 1–10.
57.
Andriyanto A, Hidayati RN. Literature review: pemanfaatan media promosi kesehatan (smartphone) dalam mencegah dan mengendalikan kadar gula Diabe-tes Tipe 2. Jurnal Ners dan Kebidanan 2018; 5(2): 172–177 (in Indonesian).